Tag: Polar Capital
Pfizer keeping tabs on AstraZeneca for potential $100 billion deal
US drug-maker Pfizer Inc has prepared a third offer to acquire Britain's AstraZeneca Plc, after refusing Pfizer’s earlier approaches for a takeover.
According to the...
Featured Article
Australian Manufacturing Week 2026 enters final run-up to Brisbane debut
Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production.
